Drawing for AZAD

USPTO serial 79073708

AZAD

Reviewed by CopyMark Law Group

Reg. 3832147Status 404
Filing date
Status date
Registration date
Aug 10, 2010
Examiner
NADELMAN, ANDREA KOYNER
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AZAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stacey R. Halpern

Stacey R. Halpern Knobbe, Martens, Olson & Bear, LLP2040 Main Street, Fourteenth FloorIrvine, CA 92614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical products, namely, pharmaceutical products and preparations for the treatment of cancer, ophthalmic, cardiovascular, neurological, respiratory, digestive and inflammatory disease; veterinary products, namely, veterinary preparations for the treatment of cancer, ophthalmic, cardiovascular, neurological, respiratory, digestive and inflammatory diseases; sanitary preparations for medical purposes; dietetic foods adapted for medical use; adjuvants for medical purposes, namely, recombinant proteins and vaccines for human purposes and for surgical and non-surgical purposes; analgesics; vermifuges; antibiotics; biological preparations for medical purposes, namely, biological preparations to produce medicines for human or veterinary use; chemical preparations for pharmaceutical purposes, namely, bismuth preparations for pharmaceutical purposes; potassium preparations for pharmaceutical purposes; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations, namely, chemical preparations for sanitary use, pharmaceutical preparations for use in chemotherapy; ferments for medical or veterinary use; hormones for medical purposes; medicinal infusions extracted from natural plants for medical and veterinary purposes; medicines for dental purposes, namely, topical and surgical anesthetics; medicines for human purposes, namely, medicines for the treatment of cancer, ophthalmic, cardiovascular, neurological, respiratory, digestive and inflammatory disease; pharmaceutical preparations, namely, for the treatment of cancer, ophthalmic, cardiovascular, neurological, respiratory, digestive and inflammatory disease; pills for pharmaceutical purposes, namely, pills containing pharmaceutical products and preparations for the treatment of cancer, ophthalmic, cardiovascular, neurological, respiratory, digestive and inflammatory disease; radiological contrast media for medical purposes; steroids ]SECTION 71 - CANCELLED—
042Scientific and technological services, namely, scientific research, technological consultation and research, all in the field of chemico-pharmaceutical preparations; industrial analysis and research services in the field of chemico-pharmaceutical preparations; biological research; chemical analysis; chemical research; chemistry services, namely chemistry consultation, research in the field of chemistry; quality control for others in the field of human and veterinary pharmaceutical preparations; quality control for others; research and development of new products for third partiesSECTION 70 - CANCELLED—
044[ Medical services; veterinary services ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 9, 2019DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 9, 2019DETHDEATH OF INTERNATIONAL REGISTRATION—
May 20, 2017INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jan 21, 2017XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jan 21, 2017XXCRGENERIC MADRID TRANSACTION CREATED—
Oct 24, 2016INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 18, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 24, 2016NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 24, 201671.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Feb 22, 2016EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jan 7, 2016PR71POST REGISTRATION ACTION MAILED - SEC.71—
Jan 6, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 24, 2015ES71TEAS SECTION 71 RECEIVED—
Jan 3, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 26, 2012ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 4, 2010FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 12, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 12, 2010FIMPFINAL DISPOSITION PROCESSED—
Nov 10, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 10, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 25, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 25, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 19, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 19, 2010ALIEASSIGNED TO LIE—
Apr 2, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 25, 2010ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2010REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 25, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 25, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 25, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 25, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2009RFNTREFUSAL PROCESSED BY IB—
Nov 10, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 9, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 9, 2009RFRRREFUSAL PROCESSED BY MPU—
Nov 9, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 6, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2009DOCKASSIGNED TO EXAMINER—
Nov 4, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 29, 2009LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED—
Oct 29, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance